17 stories tagged with #astrazeneca, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.
⌘ RSS feed for this tag → or search "Astrazeneca"
STAT+: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and more
GSK agreed to buy Nuvalent, a cancer drug developer, in a deal worth $10.6 billion, as the company continues its expansion in oncology…
AstraZeneca CFO Dr. Aradhana Sarin breaks down revenue growth goals
CelLBxHealth shares jump on partnership with AstraZeneca - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
STAT+: Pharmalittle: We’re reading about an AstraZeneca breast cancer pill, an ADAP deal in Florida, and more
The FDA extended the decision deadline for an experimental breast cancer pill from AstraZeneca after an advisory panel voted against the drug…
FDA extends review period for AstraZeneca’s camizestrant breast cancer application
US regulator delays decision on AstraZeneca cancer drug
EU panel backs AstraZeneca breast cancer drug camizestrant
AstraZeneca: 8% Q1 Revenue Growth And Imfinzi/Ultomiris Trial Data Wins
AstraZeneca's Oncology and Rare Disease segments delivered 16% and 15% growth, powered by IMFINZI and ULTOMIRIS, respectively. See why AZN stock is a strong buy.…
Low Natriuretic Peptide Levels in Obesity? HF Risk Persists
Adults with obesity may have natriuretic peptide levels below the usual rule-out threshold and still have increased odds of signs and symptoms of heart failure and other risks.…
STAT+: Supreme Court rejects challenge to Medicare drug price negotiation
The rejection may make the pharma firms remaining lawsuits more difficult.…
AstraZeneca receives FDA approval for hypertension drug Baxfendy
US regulator greenlights AstraZeneca's blood pressure drug Baxfendy - Morningstar Canada
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
AstraZeneca wins FDA approval for Enhertu in early breast cancer
AstraZeneca backs outlook as first quarter sales and profit beat hopes - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Dow Jones Top Company Headlines at 3 AM ET: AstraZeneca Gets Revenue Boost From Cancer Drugs | UBS ... - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…